Table 7, Sensitivity Analysis Showing Expected False-Positives, Colposcopies, CIN2-3 Cases, Cancer Cases, and Cancer Deaths Associated With Screening Beginning at Age 15 Years and Increased in 1-Year Increments to Age 25 Years, Among Women Followed to Age 30 Years*